Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting

BACKGROUND: Infliximab is a chimeric anti-tumor necrosis factor alpha (TNF-α) monoclonal antibody that ameliorates inflammation when it binds to and neutralizes TNF-α. It is often used in patients with Crohn’s disease and ulcerative colitis to reduce the severity of disease symptoms and induce disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Checkley, L. Allyson, Kristofek, Loretta, Kile, Samantha, Bolgar, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394553/
https://www.ncbi.nlm.nih.gov/pubmed/30311152
http://dx.doi.org/10.1007/s10620-018-5319-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394553/
https://www.ncbi.nlm.nih.gov/pubmed/30311152
http://dx.doi.org/10.1007/s10620-018-5319-6

Ejemplares similares